| CNDD | Complex neurodevelopmental disorders |
| ASD/ID | Autism Spectrum Disorder/Intellectual Disability |
| GDD | Global Developmental Delay |
| IESS | Infantile Epileptic Spasm Syndrome |
| LGS | Lennox–Gastaut Syndrome |
| DEE | Developmental and Epileptic Encephalopathy |
| ASM | Anti-Seizure Medication |
| Dup15q | Chromosome 15q duplication |
| Idic15 | Pseudoisodicentric or isodicentric chromosome 15 duplication |
| Int15 | interstitial chromosome 15 duplication |
| mTOR | Mammalian target for rapamycin |
| GATOR complex | GTPase activating protein (GAP) activity toward recombinant activating genes (RAGs) complex |
| MCD | Malformation of Cortical Development |
| SCN1A | Sodium voltage-gated channel alpha subunit 1 |
| MECP2 | Methyl-CpG binding protein 2 |
| KCNQ2/ KCNQ3 |
Voltage-gated potassium channel subunits 2 and 3 |
| UBE3A | Ubiquitin protein ligase E3A |
| ARX | Aristaless-related homeobox, X-linked |
| STXBP1 | Syntaxin-binding protein 1 |
| PWACR | Prader–Willi Angelman Critical Region |
| GABRB3 | Beta-3 subunit of the GABA-A receptor |
| GABRA5 | Alpha-5 subunit of the GABA-A receptor |
| GABRG3 | Gamma-3 subunit of the GABA-A receptor |
| SUDEP | Sudden Unexpected Death in Epilepsy Patients |
| 5HT1A | Serotonin or 5-hydroxytryptamine 1A |